An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial
- Resource Type
- Article
- Authors
- Aygören-Pürsün, Emel ; Zanichelli, Andrea ; Cohn, Danny M; Cancian, Mauro; Hakl, Roman; Kinaciyan, Tamar; Magerl, Markus; Martinez-Saguer, Inmaculada; Stobiecki, Marcin; Farkas, Henriette; Kiani-Alikhan, Sorena; Grivcheva-Panovska, Vesna; Bernstein, Jonathan A; Li, H Henry; Longhurst, Hilary J; Audhya, Paul K; Smith, Michael D; Yea, Christopher M; Maetzel, Andreas; Lee, Daniel K; Feener, Edward P; Gower, Richard; Lumry, William R; Banerji, Aleena; Riedl, Marc A; Maurer, Marcus
- Source
- In The Lancet 11-17 February 2023 401(10375):458-469
- Subject
- Primary Research
Articles
- Language
- ISSN
- 0140-6736